ProfileGDS4718 / 228109_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 59% 70% 55% 57% 53% 59% 51% 46% 58% 64% 59% 62% 53% 72% 56% 59% 60% 52% 62% 59% 65% 59% 53% 55% 58% 63% 58% 52% 48% 51% 69% 57% 43% 87% 78% 61% 54% 55% 79% 47% 61% 74% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0759859
GSM549102patient 115, normal, homogenized [OPG study]6.0555159
GSM549104patient 119, normal, homogenized [OPG study]6.8864370
GSM549108patient 138, normal, homogenized [OPG study]5.8425755
GSM549119patient 077, normal, homogenized [OPG study]5.9115757
GSM549133patient 032, cancer, homogenized [OPG study]5.6602953
GSM549139patient 042, cancer, homogenized [OPG study]6.0568259
GSM549099patient 107, normal, homogenized [OPG study]5.5588151
GSM549109patient 139, normal, homogenized [OPG study]5.3426846
GSM549110patient 046, normal, homogenized [OPG study]5.982958
GSM549114patient 063, normal, homogenized [OPG study]6.3516364
GSM549122patient 082, normal, homogenized [OPG study]6.0540959
GSM549134patient 033, cancer, homogenized [OPG study]6.2636162
GSM549136patient 036, cancer, homogenized [OPG study]5.6286853
GSM549140patient 044, cancer, homogenized [OPG study]7.0719672
GSM549111patient 047, normal, homogenized [OPG study]5.8575456
GSM549113patient 057, normal, homogenized [OPG study]6.041659
GSM549132patient 031, cancer, homogenized [OPG study]6.1260860
GSM549137patient 038, cancer, homogenized [OPG study]5.6334352
GSM549142patient 047, cancer, homogenized [OPG study]6.3034862
GSM549100patient 110, normal, homogenized [OPG study]6.0387659
GSM549107patient 135, normal, homogenized [OPG study]6.4660565
GSM549115patient 068, normal, homogenized [OPG study]6.0221459
GSM549116patient 072, normal, homogenized [OPG study]5.6615353
GSM549120patient 078, normal, homogenized [OPG study]5.8348955
GSM549131patient 030, cancer, homogenized [OPG study]5.9448558
GSM549118patient 074, normal, homogenized [OPG study]6.3205163
GSM549129patient 027, cancer, homogenized [OPG study]6.0421158
GSM549123patient 088, normal, homogenized [OPG study]5.5967952
GSM549124patient 006, cancer, homogenized [OPG study]5.4163848
GSM549126patient 015, cancer, homogenized [OPG study]5.5448251
GSM549128patient 025, cancer, homogenized [OPG study]6.8692869
GSM549103patient 117, normal, homogenized [OPG study]5.9762457
GSM549117patient 073, normal, homogenized [OPG study]5.0960343
GSM549138patient 041, cancer, homogenized [OPG study]8.7537487
GSM549141patient 045, cancer, homogenized [OPG study]7.7192378
GSM549130patient 028, cancer, homogenized [OPG study]6.1924661
GSM549101patient 111, normal, homogenized [OPG study]5.7562154
GSM549105patient 128, normal, homogenized [OPG study]5.8138555
GSM549106patient 134, normal, homogenized [OPG study]7.9253579
GSM549112patient 048, normal, homogenized [OPG study]5.3476447
GSM549125patient 011, cancer, homogenized [OPG study]6.159961
GSM549127patient 024, cancer, homogenized [OPG study]7.3071474
GSM549135patient 035, cancer, homogenized [OPG study]8.0820381